Comparative Analysis of the Use of Technetium-99m Labeled Recombinant Target Molecules at Doses of 1000 and 2000 μg for Radionuclide Diagnostics of HER2-Positive Breast Cancer. Вопр. онкол. 2022, 68 (1), 60-65. https://doi.org/10.37469/0507-3758-2022-68-1-60-65.